REUTERS
Tackling the challenges of reversing one of the world’s toughest COVID regimes would require a clear timeline and strategy for booster shots in a nation of 1.4 billion people that has gone its own way on inoculations, say infectious-disease and vaccine experts. “In every conversation that we have had on Asia’s macro outlook, the number one question that investors have is on when China will reopen and what the roadmap would look like,” Morgan Stanley economists wrote in a research note last week.
Before exposing China’s people to new COVID risk, authorities must prepare a healthcare system with wide inequality in the geographical distribution of resources for a surge in infections and adjust its messaging to people accustomed to the extremes of zero-COVID. Homegrown mRNA vaccines in development have not been green-lighted domestically, but Indonesia said last week it had approved emergency use of an mRNA vaccine developed by China’s Walvax Biotechnology Co Ltd.
Two executives expressed skepticism whether regulators would let new candidates skip early-stage trials in unvaccinated people, a group increasingly difficult to gather, even though such shots are more likely to be used as a booster.
Philippines Latest News, Philippines Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: bworldph - 🏆 9. / 68 Read more »
Source: bworldph - 🏆 9. / 68 Read more »
Source: bworldph - 🏆 9. / 68 Read more »
Source: bworldph - 🏆 9. / 68 Read more »
Source: bworldph - 🏆 9. / 68 Read more »